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Korean women with a history of gestational diabetes mellitus (GDM) have a 3.5 times greater risk of developing postpartum dia-
betes than the general population. The incidence of type 2 diabetes mellitus in early postpartum is reported as 10-15% in Korean 
women. A prospective follow-up study on Korean women with GDM showed that approximately 40% of women with previous 
GDM were expected to develop diabetes within 5 years postpartum. Independent risk factors for the development of diabetes in 
Korean women with previous GDM are pre-pregnancy body weight, gestational age at diagnosis, antepartum hyperglycemia on 
oral glucose tolerance test, low insulin response to oral glucose load, and family history of diabetes. Women with postpartum di-
abetes have greater body mass indexes, body weight, and waist circumferences than women with normal glucose tolerance. Mul-
tiple logistic regression analysis has revealed that waist circumference is the strongest obesity index along with systolic blood 
pressure and that triglyceride levels are a major independent risk factor for developing diabetes. These results in Korean women 
with previous GDM underline the importance of postpartum testing in Korean women diagnosed with GDM, and demonstrate 
that impaired B-cell function, obesity, and especially visceral obesity, are associated with the development of diabetes.
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INTRODUCTION
Gestational diabetes mellitus (GDM) is defined as glucose in-
tolerance of variable severity with onset or first recognition 
during pregnancy [1]. The prevalence of GDM is reported as 
~14% of all pregnancies in the US [2], and has been increasing 
in multiethnic populations [3]. In Korea, 2% to 5% of all preg-
nant women reportedly develop GDM [4]. The clinical impli-
cations of GDM are primarily associated with adverse out-
comes in pregnancy, such as preeclampsia, Cesarean delivery, 
macrosomia, and birth trauma [5]. In addition, women with 
GDM are at an increased risk for type 2 diabetes mellitus 
(T2DM) later in life [6].
  Women with GDM during pregnancy have a greater risk for 
development of T2DM postpartum. An original study by 
O’Sullivan and Mahan [7] that produced criteria for the diag-
nosis of GDM, aimed to determine the level of glycemia dur-
ing pregnancy that could identify subjects at risk for T2DM in 
the future. Although most women with GDM exhibit normal 
glucose tolerance (NGT) when tested several weeks postpar-
tum, impaired B-cell function and/or increased insulin resis-
tance has been reported in these women [8,9], and a substan-
tial proportion of women with previous GDM will eventually 
develop T2DM [2,10,11].
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  In this article, I will discuss the prevalence and risk factors 
of postpartum glucose intolerance in women with GDM, es-
pecially in Korean women and summarize recent findings on 
prevention of T2DM in women with previous GDM. 
INCIDENCE OF T2DM IN WOMEN WITH 
PREVIOUS GDM
Several studies from North America have reported postpartum 
T2DM rates ranging from 3% to 38% within 1 year after deliv-
ery, depending on ethnicity and the proportion of participants 
with severe hyperglycemia during pregnancy [12-15]. Within 
1 year of delivery, a high incidence of diabetes (38%) in wom-
en with GDM has been reported in a mixed ethnic population 
[12]. Using National Diabetes Data Group (NDDG) criteria, 
Kjos et al. [13] found that 9% of predominantly Hispanic wom-
en with GDM developed T2DM in early postpartum. Catala-
no et al. [14] reported that 3% of subjects in a study popula-
tion of predominantly white women developed diabetes post-
partum. Furthermore, Dacus et al. [15] reported a 10% rate of 
developing diabetes in a population of predominantly black 
women with GDM, using the same diagnostic criteria. 
  A study of mixed ethnic populations in Chicago showed that 
the cumulative incidence of T2DM in women with previous 
GDM increased rapidly in the first 2 years after delivery, and 
approximately 50% of women with GDM progressed to T2DM 
within 5 years postpartum [10]. A systemic review on the de-
velopment of diabetes in previous GDM cases by Kim et al. [2] 
demonstrated that the cumulative incidence of T2DM increased 
rapidly in the first 5 years after delivery and appeared to plateau 
after 10 years. The conversion rate to diabetes in women with 
previous GDM among ethnic groups becomes similar after 
adjusting for length of follow-up and proportion of participants 
in follow-up testing. 
  There have been limited studies on postpartum glucose in-
tolerance in Asian women with previous GDM. Kim et al. [16] 
in South Korea evaluated 211 women with GDM at 6 weeks 
postpartum and found that 9.5% had developed T2DM and 
9% had impaired glucose tolerance (IGT). Another study from 
South Korea showed that incidences of T2DM and IGT were 
15.1% and 23.2%, respectively, in 311 women with GDM at 2 
months postpartum [11]. A study of 120 Chinese women with 
GDM diagnosed using World Health Organization (WHO) 
criteria showed that 13.3% of women had IGT (8.3%) or T2DM 
(5%) at 1 year following delivery [17]. Another study of 800 
Chinese women in Hong Kong demonstrated that the incidenc-
es of diabetes and IGT were 13% and 22%, respectively, at 6 
weeks postpartum [18]. 
  The incidence of postpartum diabetes in Korean women 
with GDM is somewhat lower than described by Metzger et al. 
[12], but the proportion of GDM class A2 and B1 in this popu-
lation is greater than in other Korean studies. In addition, the 
proportion of GDM class A2 and B1 in a study by Kim et al. 
[16] was 20%; lower than any other Korean study [11]. Thus, 
the difference in incidence of diabetes among ethnic groups at 
early postpartum may be affected by the proportion of partici-
pants with severe hyperglycemia during pregnancy. 
  Cho et al. [19] performed a multi-center prospective study 
in South Korea to evaluate the incidence of diabetes in women 
with previous GDM. During the first 6 years after delivery 
(mean duration of follow-up, 2.1±1.8 years), 12.8% and 13.2% 
of 909 women with previous GDM who had not been diag-
nosed with T2DM at 6-8 weeks postpartum, developed either 
T2DM or IGT, respectively. Cumulative incidence of T2DM in 
these women is shown in Fig. 1. Cho et al. demonstrated that, 
when the data were analyzed using a 5-year postpartum sur-
vival analysis, the incidence rate of T2DM was approximately 
41% in Korean women with previous GDM. A long-term fol-
low-up study (median duration of follow-up, 8 years) of Chi-
nese women with previous GDM in Hong Kong showed that 
12% of 67 women had T2DM [20]. Differences in the inci-
dence of postpartum diabetes between Korean and Chinese 
women might be attributable to differences in diagnostic meth-
ods and criteria for GDM. Another study of South Indian wom-
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Fig. 1.  Cumulative incidence of type 2 diabetes mellitus in 
909 Korean women with previous gestational diabetes melli-
tus.Gestational diabetes mellitus in Korea
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en reported that 37% of 35 women with previous GDM had 
T2DM 5 years after delivery [21].
  The Diabetes Prevention Program (DPP) demonstrated that 
women with a history of GDM had a 71% increased risk of de-
veloping T2DM, as compared with women without such a his-
tory [22]. In comparing the risk for developing diabetes in Ko-
rean women with previous GDM with the general population, 
or with women with NGT during pregnancy, Lee et al. [23] re-
ported that Korean women with previous GDM had a 3.5 
times greater risk for T2DM, and history of GDM was a great-
er risk factor than family history of diabetes or waist circum-
ference. In other Asian studies, it was reported that the odds 
ratio (OR) for development of T2DM is 3.8 in Hong Kong [20] 
and 35.5 in South India [21]. A recent study from Australia 
showed that women with previous GDM had a 9.6 times great-
er risk for developing diabetes, and Asian women had a 2.1 
times higher risk, as compared with Caucasian women [24]. 
Another recent study from the UK also demonstrated that 
South Asian women had a higher risk of developing diabetes, 
as compared with Caucasian women (48.6% vs. 25.0%), within 
a mean period of 4.38 years after delivery [25]. 
RISK FACTORS FOR T2DM IN WOMEN WITH 
GDM
Several investigators have performed multivariate analysis to 
identify independent factors associated with developing T2DM. 
Factors associated with developing diabetes included the de-
gree of hyperglycemia (fasting glucose measured by oral glu-
cose tolerance test [OGTT], area under the curve [AUC] using 
OGTT) during pregnancy, gestational age at diagnosis of GDM, 
insulin treatment during pregnancy, maternal age, and pre-
pregnancy body mass index (BMI) [2]. A recent systemic re-
view of a study that aimed to predict T2DM in women with 
previous GDM, demonstrated that fasting glucose levels mea-
sured with an antepartum diagnostic OGTT was the most sig-
nificant predictor of T2DM (OR range, 11.1 to 21.0). Two-hour 
glucose levels (OR range, 1.02 to 1.03) and AUC on OGTT 
(OR range, 3.64 to 15) were also significant predictors [26]. 
  A study of Korean women with previous GDM found that 
age, height, and pre-pregnancy weight in women with post-
partum diabetes were greater than in women with NGT (Table 
1). Gestational age at diagnosis of GDM was lower in women 
with postpartum diabetes, as compared with women with NGT. 
Plasma glucose levels measured by a diagnostic OGTT were 
highest in women with postpartum diabetes and lowest in 
women with NGT. However, 1-, 2-, and 3-hour insulin levels 
showed a reverse trend. Women with postpartum NGT had 
the highest insulin levels. When multiple logistic regression 
analysis was applied to find independent risk factors for post-
partum diabetes, pre-pregnancy weight, gestational age at di-
agnosis, 2-hour glucose levels, and 3-hour insulin concentra-
tions using a diagnostic OGTT were independent predictors 
for developing T2DM [11]. Kim et al. [16] also demonstrated 
that the AUC on an antepartum OGTT, family history of dia-
betes, and gestational age at GDM diagnosis were independent 
predictors of both postpartum diabetes and postpartum IGT. 
Cho et al. [19], who performed a multi-center prospective study 
on Korean women with previous GDM, found that women 
with diabetes had greater BMI, body weight, and waist cir-
cumferences than women with NGT. Multiple logistic regres-
sion analysis revealed that waist circumference is the strongest 
obesity index, along with systolic blood pressure, and that tri-
glyceride levels are the major independent risk factor for de-
veloping diabetes.
  The association between postpartum diabetes and the se-
verity of hyperglycemia during pregnancy in women with pre-
vious GDM has also been documented in other ethnic groups 
[2,10,12-14,26,27]. Observations of impaired B-cell function 
as an independent predictor for T2DM in Korean women [11] 
is in agreement with several studies in the US [10,27,28]. Al-
though pre-pregnancy weight and BMI in Korean women with 
GDM is typically considerably lower than in other study pop-
ulations (especially in North American studies), pre-pregnan-
cy weight and waist circumference have been found to be in-
dependent risk factors for postpartum diabetes in Korean wom-
en [11,19]. A study of Chinese women in Hong Kong also not-
ed that maternal BMI was only marginally associated with 
postpartum diabetes in women with previous GDM. Several 
studies in North America have also revealed that maternal BMI 
is an independent risk factor for postpartum diabetes [10,29, 
30]. In particular, Metzger et al. [10] reported that women with 
previous GDM and diabetes in early postpartum had impaired 
B-cell function, and later onset of diabetes was independently 
associated with pre-pregnancy weight and impaired insulin 
secretion at diagnosis of GDM.
  Recently, Xiang et al. [31] studied 72 Hispanic women to 
identify prognostic factors associated with postpartum diabe-
tes up to 12 years following delivery. They found that low insu-
lin sensitivity and impaired B-cell function (low B-cell com-Jang HC
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pensation for insulin resistance) at baseline were independent-
ly associated with the development of diabetes. In the follow-
up period, body weight (fat) gain and rates of decline in beta 
cell compensation were significantly associated with postpar-
tum diabetes. Lim et al. [32] performed a case-control study 
on Korean women with previous GDM to investigate insulin 
sensitivity and body composition (especially visceral fat at the 
postpartum evaluation) as contributors to the development of 
impaired glucose metabolism after delivery. They found that 
visceral fat was greater in women with IGT than in age- and 
BMI-matched women with NGT or normal control women. 
The insulin sensitivity index was lower in women with IGT 
than those with NGT or normal control women. B-cell func-
tion, as measured by the acute insulin response to glucose, was 
also lower in women with IGT. They concluded that visceral 
obesity and a low insulin response to glucose might contribute 
simultaneously to the development of impaired glucose me-
tabolism in Korean women with previous GDM. 
  In summary, Korean women with previous GDM had a sim-
ilar incidence of postpartum diabetes and the risk factors for 
development of diabetes in these women were also similar to 
those found in North American women. 
POSTPARTUM SCREENING AND 
PREVENTION OF DIABETES IN WOMEN 
WITH PREVIOUS GDM
The American Diabetes Association (ADA) recommends 
screening for diabetes in women with GDM at 6-12 weeks post-
partum by measuring fasting plasma glucose or with a 75 g 
OGTT [33]. Women should then be reevaluated every 3 years 
if their glucose tolerance status is NGT. The American College 
of Obstetrics and Gynecology (ACOG) suggests that postpar-
tum screening for T2DM be performed at the first postpartum 
visit [34]. ACOG does not recommend but suggests postpar-
tum screening in women with GDM, citing the lack of long-
term studies that support the benefits of testing. However, a 
survey of ACOG Fellows in 2004 found that 75% of partici-
Table 1.  Antepartum clinical and metabolic characteristics of Korean women with GDM 
Glucose tolerance status post-partum 
P value
NGT (n=192, 61.7%) IGT (n=72, 23.2%) Diabetes (n=47, 15.1%)
Age, yr 30.4±3.9
a 31.5±4.3 31.7±4.1
a 0.04
Height, cm 157.7±4.9
a 158.0±4.4 159.6±5.1
a 0.04
Pre-pregnancy
Weight, kg 55.6±8.6
a,b 58.4±9.4
a 59.5±10.2
b 0.01
BMI, kg/m
2 22.4±3.3
a 23.3±3.6
a 23.3±3.6 0.07
Family history of diabetes, % 34.7
a 50.7
a 48.9 0.03
Gestational age at diagnosis of GDM, wk 28.9±2.8
a 28.4±4.7
b 25.9±5.5
a,b 0.001
Diagnostic OGTT
Glucose, mmol/L
Fasting 5.0±0.9
a,b 5.6±1.3
a,c 6.8±1.8
b,c 0.001
1 hr 11.0±1.3
a 11.4±1.8
b 13.2±3.1
a,b 0.001
2 hr 10.1±1.4
a,b 11.0±2.2
a,c 13.6±3.6
b,c 0.001
3 hr 8.2±1.7
a,b 9.2±2.2
a,c 11.6±3.5
b,c 0.001
Insulin, pmol/L
Fasting 65±28 68±32 61±24 0.40
1 hr 364±230
a,b 290±199
a,c 190±107
b,c 0.001
2 hr 534±387
a,b 424±460
a,c 266±176
b,c 0.001
3 hr 403±250
a 345±265
b 244±149
a,b 0.001
GDM, gestational diabetes mellitus; NGT, normal glucose tolerance; IGT, impaired glucose tolerance; BMI, body mass index; OGTT, oral glu-
cose tolerance test.
abcP < 0.05; values in each line that share the same symbol are significantly different. Gestational diabetes mellitus in Korea
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pants performed routine postpartum screening, and 51% used 
the 75 g OGTT [35]. 
  Both the ADA and ACOG recommend that women with 
previous GDM be educated or counseled about lifestyle chang-
es including diet, exercise, and weight reduction [33,34]. 
  Several studies have revealed that lifestyle intervention is ef-
fective in the prevention or delay of developing T2DM in high 
risk populations [36-38]. The DPP demonstrated that lifestyle 
intervention reduces the incidence of T2DM by 58% (95% 
confidence interval [CI], 48% to 66%) and metformin by 31% 
(95% CI, 17% to 43%) in diverse ethnic people with IGT, as 
compared with a placebo [36]. An ancillary study by the DPP 
enrolled women with a history of GDM and demonstrated 
that lifestyle intervention reduced the rate of development of 
T2DM by 53.4% and 49.2% in women with or without a GDM 
history, respectively, as compared with women in a placebo 
group. This reduction occurred even though the women with a 
history of GDM lost less weight than the women without a 
GDM history (1.60±0.80 kg vs. 4.03±0.40 kg at year 3, respec-
tively) during a lifestyle intervention [22]. This study also 
showed that metformin treatment was 3 times more effective 
in reducing the incidence of diabetes in women with a GDM 
history than in those without a GDM history. 
  The Troglitazone in the Prevention of Diabetes (TRIPOD) 
study demonstrated a 55% risk reduction in developing T2DM 
with troglitazone treatment [37], which was comparable with 
reductions of 53.4% for lifestyle intervention and 50.4% for 
metformin treatment in women with previous GDM in the 
DPP study. 
  An observational study of Korean women with previous 
GDM showed that a weight loss of approximately 4 kg to 5 kg 
within 3 years postpartum has a significant impact on the de-
velopment of diabetes (Jang HC, Park HK, Cho NH. Gesta-
tional diabetes in Korea: postpartum weight change and devel-
opment of type 2 diabetes [unpublished data]). When women 
with previous GDM were stratified into 3 groups based on ter-
tiles of BMI changes, the frequency of postpartum diabetes 
was 11.5% at baseline, but only 5.4% at end of the follow-up 
period in women who lowered their BMI by ≥3.8% (weight 
change, -4.8±3.0 kg). 
  In conclusion, Korean women with previous GDM had a 
similar incidence of postpartum diabetes, even though their 
BMI was relatively lower compared to Western women. Re-
duction of body weight or body fat might be also effective on 
prevention of T2DM in Korean women with previous GDM. 
Further studies on clinical trial for diabetes prevention in Ko-
rean women with previous GDM is needed.
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